March 2007. Volume 3. Number 1

Trivalent inactivated influenza vaccine in children 6 to 23 months old is safe

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L et al. M. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296:1990-7
Reviewers: Ruiz-Canela Cáceres J1, Juanes de Toledo B2.
1CS Virgen de África. Sevilla. España.
2 Equipo de Atención Primaria El Espinillo. Área 11. Madrid. España.
Correspondence: Juan Ruiz-Canela Cáceres. Email: jruizcanela@gmail.com
Reception date: /01/2007
Acceptance date: 18/02/2007
Publication date: 01/03/2007

Abstract


How to cite this article

Ruiz-Canela Caceres J, Juanes de Toledo B. La vacuna antigripal trivalente inactivada en niños de 6 a 23 meses de edad parece segura. Evid Pediatr. 2007;3:10.

AVC | Critically appraised articles

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L et al. M. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296:1990-7
Reviewers: Ruiz-Canela Cáceres J1, Juanes de Toledo B2.
1CS Virgen de África. Sevilla. España.
2 Equipo de Atención Primaria El Espinillo. Área 11. Madrid. España.
Correspondence: Juan Ruiz-Canela Cáceres. Email: jruizcanela@gmail.com
Reception date: /01/2007
Acceptance date: 18/02/2007
Publication date: 01/03/2007

How to cite this article

Ruiz-Canela Caceres J, Juanes de Toledo B. La vacuna antigripal trivalente inactivada en niños de 6 a 23 meses de edad parece segura. Evid Pediatr. 2007;3:10.

References

  1. Sanchez CA, Campins MM, Martinez G, X, Pinos TL, Hermosilla PE, Vaque RJ. Vacunación antigripal en niños ingresados en un hospital de tercer nivel. Factores asociados a las coberturas.An Pediatr (Barc ). 2006;65:331-6.
  2. Recommendations for influenza immunization of children. Pediatrics 2004;113:1441-7.
  3. Rennels MB, Meissner HC. Technical report: Reduction of the influenza burden in children. Pediatrics. 2002;110:e80.
  4. Marks S, Ciliska D, Jull A.Evaluation of studies of treatment harm. Evid Based Nurs. 2006;9:100-4.
  5. McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM et al. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics. 2005;115:453-60.
  6. Smith S, Demicheli V, Di Pietrantonj C, Harnden AR, Jefferson T, Matheson NJ, Rivetti A. Vacunas para la prevención de la influenza en niños sanos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2006 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2006 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
  7. Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass Ch, et al. Live attenuated influenza vaccine, trivalent, is safe in children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a communitiy-based, nonrandomized, open-label trial. Pediatrics. 2005;116:e397-407.
01/03/2007

Linked Comment